Abstract
Nerium oleander Linn. (Family: Apocynaceae) is a Ayurvedic traditional ornamental plant in Indian gardens useful in various ailments including indigestion, malaria, leprosy, mental and venereal diseases. It is also used as cardiac tonic, aborifacient, diuretic, molluscicide and insecticide and for the treatment of epilepsy, snake bites and skin condition such as leprosy, pruritus, ulcers, ringworm infection, and scabies. Preliminary neuropsychopharmacological screening also revealed cognition enhancing ability of this plant, especially the flower extract. The present study aims at evaluating the potential effectiveness of the methanol extract of the flowers of this plant in dementia related to Alzheimer’s disease (AD), owing to its inherent cognition enhancing ability. Dementia was induced in animals by feeding excess Copper and Aluminium in drinking water and confirmed by Radial 8 arm maze test. Several biochemical parameters were also estimated including superoxide dismutase (SOD), glutathione-oxidized (GSSG), reduced glutathione (GSH), nitrite estimation, myeloperoxidase (MPO) activity and acetylcholinesterase (AChE) activity. Lipid profile was also investigated along with the histopathological observations to further strengthen the results of the study. Results indicated a neuroprotective profile of the methanol extract of the flowers of N. oleander L. as well as revealed a reversal of the dementia.
Keywords: Dementia, Alzheimer's disease, Nerium oleander, acetylcholinesterase, neuroprotective, Radial 8 arm maze, superoxide dismutase, myeloperoxidase, rat model, methanolic extract.
The Natural Products Journal
Title:Neuroprotective Appraisal of Methanolic Extract of Flowers of Nerium oleander in a Non Classical Rat Model of Alzheimer Disease
Volume: 2 Issue: 3
Author(s): Kumar G. Singhal and Ghanshyam D. Gupta
Affiliation:
Keywords: Dementia, Alzheimer's disease, Nerium oleander, acetylcholinesterase, neuroprotective, Radial 8 arm maze, superoxide dismutase, myeloperoxidase, rat model, methanolic extract.
Abstract: Nerium oleander Linn. (Family: Apocynaceae) is a Ayurvedic traditional ornamental plant in Indian gardens useful in various ailments including indigestion, malaria, leprosy, mental and venereal diseases. It is also used as cardiac tonic, aborifacient, diuretic, molluscicide and insecticide and for the treatment of epilepsy, snake bites and skin condition such as leprosy, pruritus, ulcers, ringworm infection, and scabies. Preliminary neuropsychopharmacological screening also revealed cognition enhancing ability of this plant, especially the flower extract. The present study aims at evaluating the potential effectiveness of the methanol extract of the flowers of this plant in dementia related to Alzheimer’s disease (AD), owing to its inherent cognition enhancing ability. Dementia was induced in animals by feeding excess Copper and Aluminium in drinking water and confirmed by Radial 8 arm maze test. Several biochemical parameters were also estimated including superoxide dismutase (SOD), glutathione-oxidized (GSSG), reduced glutathione (GSH), nitrite estimation, myeloperoxidase (MPO) activity and acetylcholinesterase (AChE) activity. Lipid profile was also investigated along with the histopathological observations to further strengthen the results of the study. Results indicated a neuroprotective profile of the methanol extract of the flowers of N. oleander L. as well as revealed a reversal of the dementia.
Export Options
About this article
Cite this article as:
G. Singhal Kumar and D. Gupta Ghanshyam, Neuroprotective Appraisal of Methanolic Extract of Flowers of Nerium oleander in a Non Classical Rat Model of Alzheimer Disease, The Natural Products Journal 2012; 2 (3) . https://dx.doi.org/10.2174/2210315511202030235
DOI https://dx.doi.org/10.2174/2210315511202030235 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases
Current Clinical Pharmacology In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs
Current Pharmaceutical Design Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases
Current Neuropharmacology Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Applications of Nanosystems to Anticancer Drug Therapy (Part II. Dendrimers, Micelles, Lipid-based Nanosystems)
Recent Patents on Anti-Cancer Drug Discovery Synthesis and Evaluation of Anticonvulsant Activity of Some N-[(4-Chlor- 2-methylphenoxy)ethyl]- and N-[(4-Chlor-2-methylphenoxy)acetyl]aminoalkanols
Letters in Drug Design & Discovery Preface
Current Neuropharmacology Editorial (Adverse Effects, Adverse Events and Side-Effects: Does the Terminology Matter?
Current Drug Safety Will Medicinal Cannabinoids Prove to be Useful Clinically?
Current Drug Therapy Formulation of Extended-Release Beads of Lamotrigine Based on Alginate and <i>Cassia fistula</i> Seed Gum by QbD Approach
Current Drug Delivery Whole Embryo Culture: An Important Tool in Developmental Toxicology Today
Current Pharmaceutical Design <i>In Vivo</i> Longitudinal Monitoring of Changes in the Corpus Callosum Integrity During Disease Progression in a Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Applications and Synthesis of the Antiepileptic Drug Oxcarbazepine and Related Structures
Current Organic Chemistry Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Modulation of GABAA Receptors by Natural Products and the Development of Novel Synthetic Ligands for the Benzodiazepine Binding Site
Current Drug Targets Anticonvulsant and Antitubercular Activities of 6-Phenyl/Biphenyl-4-yl-2- [2-(pyridin-2-ylamino)-ethyl]- and 6-(Biphenyl-4yl)-2-(2N-subtituted amin- 1-yl)-ethyl derivatives of 4,5-dihydropyridazin-3(2H)-one
Letters in Drug Design & Discovery Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Neurotrophin Receptor Signaling as a Therapeutic Target for Huntington's Disease
CNS & Neurological Disorders - Drug Targets Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease
Current Drug Metabolism Synthesis and DPPH Radical Scavenging Activity of 5-Arylidene-N,Ndimethylbarbiturates
Medicinal Chemistry